Powered by Axial Data

Top Biotechnology Private Equity Funds

Explore 30 Biotechnology Private Equity Funds that source acquisition and investment opportunities on Axial’s M&A platform.

Axial Insights

Biotechnology Private Equity Funds

30

Active Firms

881

TTM Deal Inquiries

$7M-$25M

Core Revenue Range

$2M-$5M

Core EBITDA Range


Florida 17%
Texas 10%
California 8%
New York 5%
Pennsylvania 5%

Focus: Control Investments | Capital Source: Committed Capital | Operating Approach: Scale & Exit

Showing 1-20 of 30 Private Equity Funds

Sorted by recent activity

Morgan Stanley Capital Partners

2 Closed Deals via Axial 14 Total Closed Deals Actively Sourcing Deals
Morgan Stanley Capital Partners (“MSCP”), established in 1985 and based in New York, makes control equity investments in North American middle-market companies. Currently investing capital from Fund VI with $1.4 billion of total commitments. Targeted, sub-sector focused strategy with intensive operational focus driven by on-the-ground portfolio company “Accelerators” in addition to Operating Partners. We differentiate ourselves by applying the global resources, brand, and capabilities of Morgan Stanley to the middle-market. 

Recent Transactions

View All
  • Dec 2025 Acquired Confidential Company
  • Dec 2021 Acquired Simplicity
  • Oct 2012 Invested in Creative Circle
  • Apr 2012 Acquired Access Cash

Arsenal Capital Partners

1 Closed Deal via Axial 31 Total Closed Deals Actively Sourcing Deals
Arsenal Capital Partners is a specialized private equity firm with a deep focus in two sectors, Specialty Industrials and Healthcare. Since its founding in 2000, Arsenal has raised institutional equity investment funds of approximately $5.3 billion. Arsenal has completed more than 150 transactions, including platform portfolio companies and follow-on acquisitions. Arsenal specializes in the Specialty Industrials and Healthcare sectors due to their attractive growth trends, large number of technology and innovation-rich companies, and opportunities to create value-added solutions. Arsenal…

Recent Transactions

View All
  • May 2024 Acquired Confidential Company
  • May 2022 Invested in Epic Sciences
  • May 2022 Invested in OncoHealth
  • Nov 2020 Acquired MAXhealth

Envest Capital Partners

1 Closed Deal via Axial 22 Total Closed Deals Actively Sourcing Deals
Envest Capital Partners is an investment company holding long term private equity positions in established basic businesses. We invest in a relatively broad range of basic industries, with a focus on manufacturing, industrial & consumer services, and franchising. Envest seeks to provide private direct equity financing to companies with sales of $5 to $50 million, exceptional growth prospects and strong, stable cash flow. Founded in 2000, Envest is a private equity firm based in Virginia Beach, VA. We are dedicated to partnering with privately held and founder-owned businesses. The Envest…

Recent Transactions

View All
  • Aug 2023 Acquired Earl Industries Inc.
  • Aug 2023 Acquired Digital Services LLC
  • Aug 2023 Acquired Commonwealth Epoxy Coatings LLC
  • Oct 2022 Acquired CBT Logistics Group

Latticework Capital

1 Closed Deal via Axial 12 Total Closed Deals Actively Sourcing Deals
Latticework Capital OverviewHeadquartered in Dallas, Latticework Capital Management is a growth-oriented private equity firm focused exclusively on the healthcare industry with over $400 million of assets under management. Latticework leverages its over 100 combined years of healthcare and investing experience as well as its network of industry executives to help companies grow and realize their full, long-term value. For more information visit www.latticeworkcapital.com.Healthcare FocusCompetition in private equity is driving fund specialization. Similar to other large and evolving…

Recent Transactions

View All
  • Jun 2025 Acquired First Medical Associates
  • Dec 2024 Acquired Life Science Connect
  • Sep 2023 Acquired Institutes of Health
  • Aug 2022 Acquired AMERICAN CLINICAL RESEARCH SERVICES

Graham Partners

46 Total Closed Deals Actively Sourcing Deals
Graham Partners is a private investment firm focused on investing in businesses with proprietary technologies, advanced manufacturing know-how, innovative product development capabilities, and strong growth potential. Graham Partners targets companies with EBITDA between $5 million and $50 million, and will invest in smaller companies to the extent they complement one or more of its other holdings. Since the firm's founding in 1988, Graham Partners has closed over sixty acquisitions, joint ventures, financings, and divestitures. The committed capital raised since inception through the Graham…

Recent Transactions

View All
  • Sep 2023 Acquired Barcoding
  • Sep 2023 Acquired Commercial Bakeries Corp.
  • Aug 2023 Acquired TAOGLAS
  • Mar 2023 Acquired Rhythmlink

Hammond Kennedy Whitney & Company

44 Total Closed Deals Actively Sourcing Deals
HKW is evolving with clarity and purpose, while honoring the vision of the firm’s founders and our 100 plus year history. We focus on specific sectors in which we can utilize our skills and perspective, leveraging technology as part of a data-driven methodology to power our “Four Pillar” structure. HKW has developed processes that support our strategy to find, create, and sustain value in our companies while trusting and appreciating that our approach is what sets us apart.

Recent Transactions

View All
  • Jan 2023 Acquired CMIT Solutions
  • Dec 2022 Acquired dominKnow
  • Sep 2022 Acquired Golden Country Oriental Food
  • Mar 2022 Invested in Draup

Stop Browsing. Start Transacting.

Join 20,000+ members who source deals, connect with counterparties, and close transactions on Axial.

Halifax Group

25 Total Closed Deals Actively Sourcing Deals
The Halifax Group is a private investment firm dedicated to partnering with founders and managers of lower middle-market businesses with total enterprise values generally between $50 million and $300 million.

Recent Transactions

View All
  • Nov 2019 Acquired AAMP
  • Sep 2019 Acquired Prairie Industries
  • Jun 2019 Acquired StrataTech
  • Apr 2018 Acquired ChanceLight

Kainos Capital

22 Total Closed Deals Actively Sourcing Deals
Kainos Capital, a middle market private equity firm focused on the food and consumer sector, was recently formed by Andrew Rosen, Robert Sperry and Sarah Ashmore Bradley. The Kainos Partners have invested and collaborated together in the food and consumer space over the past 20 years and their deep industry knowledge is complimented by an experienced team of investment professionals.The Kainos Team has extensive investment and operating experience in the industry, having invested more than $2 billion of equity in more than 52 transactions in the food and consumer sector with a total…

Recent Transactions

View All
  • Aug 2023 Acquired Good2Grow
  • Feb 2023 Invested in CellCore
  • Jan 2023 Acquired Evriholder
  • Aug 2021 Acquired Muenster Milling Company

Artemis Capital Partners

22 Total Closed Deals Actively Sourcing Deals
Artemis is a highly specialized private equity firm focused on partnering with differentiated Industrial Tech companies that contribute to a healthier, safer, and more productive world. Focusing exclusively on manufacturers of highly engineered products with mission-critical applications, Artemis' vision is to buy and build deeply impactful Industrial Tech businesses that enhance global health, security, and productivity.These products enable some of the most important technologies to serve the most pressing human demands: Diagnostic lab equipment enabling health &…

Recent Transactions

View All
  • Nov 2025 Acquired Antenna Associates, Inc.
  • Sep 2025 Acquired Millrock Technology
  • Mar 2025 Acquired Athena AI
  • Jan 2025 Acquired Richland Glass

Peak Rock Capital

17 Total Closed Deals Actively Sourcing Deals
We make equity and debt investments in companies in North America and Europe. Peak Rock’s equity investment platform focuses on opportunities where it can support senior management to drive rapid growth and profit improvement, with expertise in corporate carve-outs and partnering with families and founders seeking first-time institutional capital. Peak Rock’s credit platform focuses on providing bespoke primary financings and making investments in secondary loans for corporate debt and commercial real estate. Peak Rock’s principals have deep expertise in complex situations and…

Recent Transactions

View All
  • Apr 2019 Acquired Turkey Hill
  • Oct 2018 Acquired Pretzels, Inc.
  • Oct 2018 Acquired Louisiana Fish Fry Products
  • Sep 2018 Acquired TNT Crust

Third Century Management, LLC

14 Total Closed Deals Actively Sourcing Deals
Third Century Investment Associates, LP ("TCIA") manages private equity capital for significant investments in small businesses. We invest actively in partnership with operating companies and carefully selected management teams located in the United States. Our team targets proven businesses in specialized sectors where we work to become advantaged investors through existing or acquired expertise. We are a disciplined, process-driven partnership, focused on long-term fundamentals. Our mission is to build sustainable business value, earn a superior return and develop a best-in-class reputation…

Recent Transactions

View All
  • Apr 2026 Acquired Mobile IV Medics
  • Sep 2025 Acquired BlackJet Marketing
  • Jul 2025 Acquired Local Web Leads
  • Oct 2024 Acquired Mobile RN Management

American Pacific Group

7 Total Closed Deals Actively Sourcing Deals
American Pacific Group is a San Francisco-based private equity firm targeting control equity investments in lower-middle-market companies, typically with EBITDA from $0 to $40 million. We focus on complex businesses and transactions across technology, consumer, business services, industrial, and healthcare. We are growth-oriented investors, and together with our in-house operating partners, seek to implement our proprietary value creation model to drive sustainable growth in our portfolio companies. 

Recent Transactions

View All
  • Aug 2022 Acquired Concisys
  • Dec 2021 Acquired Gym Launch & Prestige Labs
  • Nov 2021 Acquired Fellers
  • Mar 2021 Acquired Aesop

Sagemoore Capital

5 Total Closed Deals Actively Sourcing Deals
Sagemoore is a private equity firm focused on making investments in the lower middle-market. We utilize an evergreen fund structure with committed capital from family office investors resulting in a patient capital base.This structure offers a flexible investment horizon designed to maximize stakeholder alignment by focusing on true long-term value creation. Sagemoore’s investment principals each have more than 15 years of professional investing and healthcare operating experience.We seek to cultivate deep partnerships with entrepreneurs and experienced operating teams for the benefit of…

Recent Transactions

View All
  • Aug 2024 Advised Sagemoore Capital on an investment from Confidential Company
  • Jan 2017 Acquired Carie Health
  • Mar 2014 Invested in ServRX
  • Apr 2011 Acquired Restore Health

Gemspring Capital

2 Total Closed Deals Actively Sourcing Deals
With $350 million of committed capital under management, Gemspring Capital is a private equity firm specializing in lower middle market companies. We provide flexible capital and partner with talented management teams to propel companies to grow and achieve their full potential. At Gemspring, we take a hands-on approach to investing and commit operating and strategic resources to help drive revenue growth and operating efficiencies at each of our portfolio companies. We take smart risks with capital investment and often pursue transformational add-on acquisitions. The goal for each…

Recent Transactions

View All
  • Jun 2017 Acquired Therma
  • Dec 2016 Acquired United Group Programs

Inverness Graham

11 Total Closed Deals
Headquartered in Newtown Square, PA, Inverness Graham is an operationally focused private investment firm that has raised over $1 billion of capital since its inception. Inverness Graham acquires innovative tech-enabled manufacturing, service and software companies.Our approach is as unique as our heritage. Founded by senior executives of the Graham Group, an alliance of independent operating businesses, investment firms and philanthropic entities, we bring unparalleled resources developed over a 50-year operating history to support our portfolio companies.Inverness Graham partners with…

Recent Transactions

View All
  • Mar 2023 Acquired Innovia Medical
  • Jan 2023 Acquired Treat Planet
  • Aug 2022 Acquired Custom Agronomics
  • Feb 2022 Acquired Concord Servicing

ICV Capital Partners

10 Total Closed Deals
Founded in 1998, ICV Capital Partners is a private investment firm focused on making equity investments in America's smaller middle-market companies. ICV seeks to generate long-term capital appreciation by investing in companies with revenues between $25 million and $200 million.ICV targets companies that have a history of stable cash flows and offer the prospect of meaningful growth. These companies are leaders in their markets with highly-defensible positions. They have strong and proven management teams that are eager to invest in their company.ICV Growth Partners was launched in 2009 to…

Recent Transactions

View All
  • Apr 2011 Acquired Cargo Airport Services
  • Jan 2011 Acquired Stauber Performance Ingredients
  • Oct 2010 Acquired Press-A-Print International, LLC
  • Oct 2010 Acquired Public Financial Management, Inc.
Graham Healthcare Capital (GHCC) employs a Berkshire Hathaway-like model, providing permanent capital solutions to acquire middle-market healthcare companies. This strategy allows for decision-making with a long-term mindset that is best for the ongoing viability of the company. Our principals bring significant healthcare operational expertise to our partnerships with business owners. Graham Healthcare Capital is an affiliate of Graham Healthcare Group which is owned and managed by Graham Holdings Company (NYSE:GHC). GHC is a diversified holding company whose operations include educational…

Recent Transactions

View All
  • Aug 2023 Acquired Allegheny Health Network
  • Aug 2023 Acquired CSI Pharmacy
  • Aug 2023 Acquired Weiss Medical
  • Aug 2023 Acquired Darby

Acasta Capital

3 Total Closed Deals
Acasta Capital is a boutique merchant bank and advisory firm formed to bring together individuals with unique experiences and track records to create greater value for clients and partners based on inventive and do-able ideas. Being free of the conflicts and limitations too common in the advisory sector, our business model is founded on the principle of aligned interests with clients and partners. We provide advice on transformational change, mergers and acquisitions, financial restructurings, capital structure, investor activism and strategy.

Recent Transactions

View All
  • Jan 2017 Acquired Stellwagen Group
  • Jan 2017 Acquired Jempak
  • Jan 2017 Acquired Apollo

Spindletop Capital

2 Total Closed Deals
Spindletop Capital is a growth capital investment firm focused on providing expansion capital for commercial stage healthcare companies. Based in Austin, Spindletop is managed by an unrivaled team of investment professionals and advisors with deep operating, technical, and transactional experience. Spindletop Capital invests nationally where it can leverage the organization’s deep experience, broad network and proprietary access to Texas resources to create incremental value for management teams and financing syndicates across all sectors of healthcare including medical devices,…

Recent Transactions

View All
  • Jun 2012 Invested in Qspex Technologies
  • Jan 2012 Invested in Bioventus
Laidlaw & Company is a full-service investment banking and brokerage firmoffering personalized investment advice and skillful execution to private and public institutions,as well as high net worth individual investors.

Recent Transactions

View All
  • Jun 2010 Advised LinkedIn on an investment from Private Investor
  • Mar 2010 Advised Facebook on an investment from Private Investor

Frequently Asked Questions

How are Private Equity Funds in this directory ordered?

Firms in the Biotechnology Private Equity Funds directory are ordered based on recent deal activity on Axial. The default order reflects observed market signals rather than a subjective ranking of firm quality.

What information is included in each Private Equity Fund profile?

Each profile provides information about the firm’s areas of focus, transaction criteria, and relevant activity on Axial’s M&A platform. Together, these details provide a clearer view of where a firm is active and the types of companies and opportunities most relevant for it.

What company sizes are most common for Biotechnology Private Equity Funds?

Based on activity on Axial’s M&A platform, the core revenue range for Biotechnology Private Equity Funds is $7M-$25M, with a core EBITDA range of $2M-$5M. Company size can be an important indicator of fit, as firms often concentrate their experience, resources, and transaction activity within particular segments of the market.

How important is Life Sciences experience when evaluating Private Equity Funds?

Relevant Life Sciences experience can be an important consideration when evaluating a firm. Familiarity with the sector can provide a stronger understanding of its business models, market dynamics, valuation considerations, and transaction environment. The 30 firms included in this directory provide a starting point for identifying firms with relevant experience and activity in Life Sciences.

Do all Private Equity Funds in this directory focus exclusively on Life Sciences?

Not necessarily. Many firms are active across multiple industries, so inclusion in the Biotechnology Private Equity Funds directory reflects relevant experience or activity in Life Sciences, rather than an exclusive sector focus. Individual profiles provide additional context on each firm’s areas of focus and activity within the sector.

How do I compare Private Equity Funds with experience in Life Sciences?

When comparing Private Equity Funds with experience in Life Sciences, consider factors such as size range, geographic reach, and recent transaction activity. These characteristics vary across the 30 firms included in the directory and can help identify firms that align with your needs.

How do I connect with Biotechnology Private Equity Funds?

Axial can help you identify and connect with firms based on your objectives and what you are looking to accomplish. The process varies depending on your role and transaction needs. If you are interested in connecting with firms in the Biotechnology Private Equity Funds directory, you can request information here.


Want to Keep Exploring?

Enter your details to access all firm profiles.

Let us curate Relevant Introductions.

Rather than a one-off introduction to company, work with an Axial Exit Consultant to find the best options from our network of 2,500 M&A advisors — at no cost to you.

Companies sold using Axial Advisor Finder:

Get Introduced to the Right Advisors

This service is complimentary and all information is confidential. Looking to learn more? Complete the form above.

By providing telephone number and submitting the form you are consenting to be contacted by SMS text message. Message & data rates may apply. Reply STOP to opt of further messaging.

We've Received Your Request

A member of our team will follow up to coordinate next steps.

Explore Axial
Template